The online version of this article (doi:10.1186/cc10419) contains supplementary material, which is available to authorized users.
The authors declare that they have no competing interests.
HHC participated in the design of the study, collected data, performed the statistical analysis, and drafted the manuscript. CCH participated in the design of the study, analyzed and interpreted data, and revised the manuscript. CHL acquired surgical samples, and helped to collect data. HYC performed the statistical analysis, and helped to revise the manuscript. MYC, WHS, SMH, and HYS participated in clinical evaluation of patients, and helped to collect data. CCH conceived of the study, participated in its design and coordination, and revised the manuscript. CJY participated in the design and coordination of the study. All authors read and approved the final manuscript.
Although access to highly active antiretroviral therapy (HAART) has prolonged survival and improved life quality, HIV-infected patients with severe immunosuppression or comorbidities may develop complications that require critical care support in intensive care units (ICU). This study aimed to describe the etiology and analyze the prognostic factors of HIV-infected Taiwanese patients in the HAART era.
Medical records of all HIV-infected adults who were admitted to ICU at a university hospital in Taiwan from 2001 to 2010 were reviewed to record information on patient demographics, receipt of HAART, and reason for ICU admission. Factors associated with hospital mortality were analyzed.
During the 10-year study period, there were 145 ICU admissions for 135 patients, with respiratory failure being the most common cause (44.4%), followed by sepsis (33.3%) and neurological disease (11.9%). Receipt of HAART was not associated with survival. However, CD4 count was independently predictive of hospital mortality (adjusted odds ratio [AOR], per-10 cells/mm3 decrease, 1.036; 95% confidence interval [CI], 1.003 to 1.069). Admission diagnosis of sepsis was independently associated with hospital mortality (AOR, 2.91; 95% CI, 1.11 to 7.62). A hospital-to-ICU interval of more than 24 hours and serum albumin level (per 1-g/dl decrease) were associated with increased hospital mortality, but did not reach statistical significance in multivariable analysis.
Respiratory failure was the leading cause of ICU admissions among HIV-infected patients in Taiwan. Outcome during the ICU stay was associated with CD4 count and the diagnosis of sepsis, but was not associated with HAART in this study.
Authors’ original file for figure 113054_2011_9639_MOESM1_ESM.tiff
Crothers K, Huang L, Goulet JL, Goetz MB, Brown ST, Rodriguez-Barradas MC, Oursler KK, Rimland D, Gibert CL, Butt AA, Justice AC: HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med. 2011, 183: 388-395. 10.1164/rccm.201006-0836OC. PubMedPubMedCentralCrossRef
Rosen MJ, Narasimhan M: Critical care of immunocompromised patients: human immunodeficiency virus. Crit Care Med. 2006, 34 (Suppl 9): 245-250. CrossRef
Rosenberg AL, Seneff MG, Atiyeh L, Wagner R, Bojanowski L, Zimmerman JE: The importance of bacterial sepsis in intensive care unit patients with acquired immunodeficiency syndrome: Implications for future care in the age of increasing antiretroviral resistance. Crit Care Med. 2001, 29: 548-556. 10.1097/00003246-200103000-00013. PubMedCrossRef
Zolopa A, Andersen J, Powderly W, Sanchez A, Sanne I, Suckow C, Hogg E, Komarow L: Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS One. 2009, 4: e5575-10.1371/journal.pone.0005575. PubMedPubMedCentralCrossRef
Vargas-Infante YA, Guerrero ML, Ruiz-Palacios GM, Soto-Ramírez LE, Del Río C, Carranza J, Domínguez-Cherit G, Sierra-Madero JG: Improving outcome of human immunodeficiency virus-infected patients in a Mexican intensive care unit. Arch Med Res. 2007, 38: 827-833. 10.1016/j.arcmed.2007.05.007. PubMedCrossRef
Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents, Office of AIDS Research Advisory Council: Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. 2007, [ http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf]
Armbruster C, Pokieser L, Hassl A: Diagnosis of Pneumocystis carinii pneumonia by bronchoalveolar lavage in AIDS patients: comparison of Diff-Quik, fungifluor stain, direct immunofluorescence test and polymerase chain reaction. Acta Cytol. 1995, 39: 1089-1093. PubMed
Hung CC, Hsiao CF, Chen MY, Hsieh SM, Chang SY, Sheng WH, Sun HY, Chang SC: Improved survival of persons with human immunodeficiency virus type 1 infection in the era of highly active antiretroviral therapy in Taiwan. Jpn J Infect Dis. 2006, 59: 222-228. PubMed
Sun HY, Chen MY, Hsieh SM, Sheng WH, Chang SY, Hsiao CF, Hung CC, Chang SC: Changes in the clinical spectrum of opportunistic illnesses in persons with HIV infection in Taiwan in the era of highly active antiretroviral therapy. Jpn J Infect Dis. 2006, 59: 311-316. PubMed
Müller M, Wandel S, Colebunders R, Attia S, Furrer H, Egger M, IeDEA Southern and Central Africa: Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis. 2010, 10: 251-261. 10.1016/S1473-3099(10)70026-8. PubMedPubMedCentralCrossRef
Wittkop L, Günthard HF, de Wolf F, Dunn D, Cozzi-Lepri A, de Luca A, Kücherer C, Obel N, von Wyl V, Masquelier B, Stephan C, Torti C, Antinori A, García F, Judd A, Porter K, Thiébaut R, Castro H, van Sighem AI, Colin C, Kjaer J, Lundgren JD, Paredes R, Pozniak A, Clotet B, Phillips A, Pillay D, Chêne G, The EuroCoord-CHAIN study group: Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study. Lancet Infect Dis. 2011, 11: 363-371. 10.1016/S1473-3099(11)70032-9. PubMedCrossRef
Chang SY, Chen MY, Lee CN, Sun HY, Ko W, Chang SF, Chang KL, Hsieh SM, Sheng WH, Liu WC, Wu CH, Kao CL, Hung CC, Chang SC: Trends of antiretroviral drug resistance in treatment-naive patients with human immunodeficiency virus type 1 infection in Taiwan. J Antimicrob Chemother. 2008, 61: 689-693. 10.1093/jac/dkn002. PubMedCrossRef
- Admissions to intensive care unit of HIV-infected patients in the era of highly active antiretroviral therapy: etiology and prognostic factors
- BioMed Central
Neu im Fachgebiet AINS
Meistgelesene Bücher aus dem Fachgebiet AINS
Mail Icon II